Related Experiment Video
Updated: Jun 22, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer
Jason P W Carey1, Ananthi J Asirvatham, Oliver Galm
1Department of Biology, Center for Cancer Research and Therapeutics Development, Clark Atlanta University, Atlanta, GA 30314, USA. j_carey84@msn.com
Background:
Inhibitor of differentiation 4 (Id4), a member of the Id gene family is also a dominant negative regulator of basic helix loop helix (bHLH) transcription factors. Some of the functions of Id4 appear to be unique as compared to its other family members Id1, Id2 and Id3. Loss of Id4 gene expression in many cancers in association with promoter hypermethylation has led to the proposal that Id4 may act as a tumor suppressor. In this study we provide functional evidence that Id4 indeed acts as a tumor suppressor and is part of a cancer associated epigenetic re-programming.
Methods:
Data mining was used to demonstrate Id4 expression in prostate cancer. Methylation specific polymerase chain reaction (MSP) analysis was performed to understand molecular mechanisms associated with Id4 expression in prostate cancer cell lines. The effect of ectopic Id4 expression in DU145 cells was determined by cell cycle analysis (3H thymidine incorporation and FACS), expression of androgen receptor, p53 and cyclin dependent kinase inhibitors p27 and p21 by a combination of RT-PCR, real time-PCR, western blot and immuno-cytochemical analysis.
Results:
Id4 expression was down-regulated in prostate cancer. Id4 expression was also down-regulated in prostate cancer line DU145 due to promoter hyper-methylation. Ectopic Id4 expression in DU145 prostate cancer cell line led to increased apoptosis and decreased cell proliferation due in part by an S-phase arrest. In addition to S-phase arrest, ectopic Id4 expression in PC3 cells also resulted in prolonged G2/M phase. At the molecular level these changes were associated with increased androgen receptor (AR), p21, p27 and p53 expression in DU145 cells.
Conclusion:
The results suggest that Id4 acts directly as a tumor suppressor by influencing a hierarchy of cellular processes at multiple levels that leads to a decreased cell proliferation and change in morphology that is possibly mediated through induction of previously silenced tumor suppressors.
Insights
Inhibitor of differentiation 4 (Id4) functions as a tumor suppressor in prostate cancer, with its down-regulation linked to promoter hypermethylation. Restoring Id4 expression inhibits cancer cell proliferation and increases apoptosis.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Inhibitor of differentiation 4 (Id4) is a dominant-negative regulator of basic helix loop helix (bHLH) transcription factors.
- Loss of Id4 expression, associated with promoter hypermethylation in many cancers, suggests a tumor suppressor role.
- This study provides functional evidence for Id4's tumor suppressor activity and its role in cancer-associated epigenetic reprogramming.
Purpose of the Study:
- To investigate the role of Id4 as a tumor suppressor in prostate cancer.
- To elucidate the molecular mechanisms underlying Id4 dysregulation in prostate cancer cells.
Main Methods:
- Data mining to assess Id4 expression in prostate cancer.
- Methylation-specific polymerase chain reaction (MSP) to analyze Id4 promoter methylation.
- Functional assays including cell cycle analysis, RT-PCR, real-time PCR, western blot, and immunocytochemistry to evaluate the effects of ectopic Id4 expression.
Main Results:
- Id4 expression is significantly down-regulated in prostate cancer, particularly in the DU145 cell line, due to promoter hypermethylation.
- Ectopic Id4 expression in DU145 cells induced apoptosis, decreased cell proliferation via S-phase arrest, and increased expression of p53, p21, p27, and androgen receptor.
- Ectopic Id4 expression in PC3 cells also led to prolonged G2/M phase arrest.
Conclusions:
- Id4 functions as a direct tumor suppressor in prostate cancer.
- Id4 influences multiple cellular processes, including cell proliferation and morphology, potentially by reactivating silenced tumor suppressors.
- Epigenetic silencing of Id4 contributes to prostate cancer development.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation
The JAK-STAT Signaling Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
